Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P64
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-0.61%
2024-22.04%
20238.67%
2022-46.79%
2021-41.22%
2020-22.97%
2019-0.52%
201843.30%
201725.00%
2016-40.33%